CV CapsoVision Quarterly EPS earnings growth

Graphic logo of capsovision.com (CV)

CapsoVision Inc management is promoting non-contact gastrointestinal diagnostics in an effort to expand insurance reimbursements. The intensity of quarterly EPS growth demonstrates fundamental resilience, with the current mark standing at -51.20. Business stability is supported by optimized equipment delivery routes and strict control over the procurement of precision optics through various contractors, which eliminates disruptions in system assembly.

capsovision.com (CV) - Year-over-year earnings per share growth for the last 12 months from 07/03/2025 to 11/10/2026

Analytical breakdowns and data insights for company CapsoVision Inc (CV)

- market value and analyst target forecast:
Price Chart capsovision.com|CV - Consensus Target
- market capitalization data:
Market Capitalization CapsoVision Medical|CV - Total Enterprise Value
- balance sheet net asset value indicators:
Book Value per Share CapsoVision Inc|CV - Accounting Capitalization|Market Capitalization to Book Value Ratio capsovision.com|CV - Company Total Asset Base
- company liabilities and liquidity data:
Total Debt to Capital CapsoVision Inc|CV - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital capsovision.com|CV - Company Aggregate Debts|Debt to Book Capitalization Ratio CapsoVision Medical|CV - Company Long-Term Debt|Company Current Liabilities CapsoVision Inc|Quick Ratio capsovision.com
- earnings and valuation multiples indicators:
CV - Company Net Income|Expected Profit CapsoVision Inc|CV - Market Cap to Net Income Ratio|Projected Price to Earnings capsovision.com|CV - PEG Multiple|EV/EBITDA Multiple CapsoVision Medical|CV - Operating income before deduction of amortization|Earnings per share for the last twelve months CapsoVision Inc|CV - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months capsovision.com|CV - Net earnings per share growth this year|Earnings growth forecast for next year CapsoVision Inc
Initial company analysis:CapsoVision Inc
Flagship merchandise of CapsoVision Inc

CapsoVision Inc (CV) is developing a high-tech business in the capsule endoscopy niche, leveraging patent protection for its optics and stringent FDA requirements. This indicator calculates the percentage change in net earnings per share between the current and previous quarters. Such a metric allows investors to identify the actual efficiency of medical device commercialization. Profit dynamics confirm the company's ability to overcome clinical validation barriers. By analyzing the quarterly EPS growth rate, one can promptly recognize a hidden business slowdown.

Direct competitors

Abbott (ABT) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Thermo Fisher Scientific Inc.|GEHC (GE Healthcare Corp) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Mettler Toledo Inc MTD|Quarterly EPS earnings growth WAT|bio-techne.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth BRKR (Bruker)|Year-over-year net earnings per share change for the last twelve months Azenta Inc (AZTA)|Varex - Quarterly EPS earnings growth|Semler (SMLR) - Year-over-year net earnings per share growth for the last 12 months|BFLY: Quarterly EPS earnings growth|mesalabs.com (MLAB) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Quantum-Si Incorporated|Year-over-year earnings per share growth for the last twelve months NNOX|Year-over-year net earnings per share growth for the last 12 months QTRX (Quanterix Corp)|MASS (908 Devices Corporation) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth MXCT (MaxCyte, Inc.)|Rapid Micro Biosystems Inc. (RPID) - Earnings per share growth in annualized terms for the last twelve months|SEER - Year-over-year earnings per share growth for the last twelve months|Net earnings per share growth for the trailing year Hyperfine Inc (HYPR)|FONR (FONAR Corp) - Year-over-year net earnings per share growth for the last 12 months|Daxor (DXR) - Quarterly EPS earnings growth|MDAI (Spectral AI, Inc.) - Quarterly EPS earnings growth|VivoSim Labs Inc (VIVS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Aclarion, Inc. (ACON)|AKYA: Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months ThermoGenesis Holdings Inc. THMO|TLIS - Year-over-year net earnings per share growth for the last 12 months|T2 Biosystems, Inc. - Quarterly EPS earnings growth